TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target.
Yu JJ, Zhou DD, Yang XX, Cui B, Tan FW, Wang J, Li K, Shang S, Zhang C, Lv XX, Zhang XW, Liu SS, Yu JM, Wang F, Huang B, Hua F, Hu ZW.
Yu JJ, et al. Among authors: shang s.
Nat Commun. 2020 Jul 21;11(1):3660. doi: 10.1038/s41467-020-17385-0.
Nat Commun. 2020.
PMID: 32694521
Free PMC article.